Tildrakizumab in the treatment of moderate-to-severe hidradenitis suppurativa.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Australas J Dermatol

Title: The Australasian journal of dermatology

Publisher: Wiley

ISSN (Electronic): 1440-0960

ISSN (Print): 0004-8380

Publication date (Electronic): Nov 2020

Volume: 61

Issue: 4

Affiliations

[1 ] Department of Dermatology, The Royal Melbourne Hospital, Parkville, Victoria, Australia.

Article

DOI: 10.1111/ajd.13377

PubMed ID: 32627843

SO-VID: 7867fd60-1570-4a88-92b4-ec134bc99284

History

Data availability:

Comments

Comment on this article

scite_

Cited by 15

See all cited by